G-CSF & Blood Growth Factor Support

Febrile neutropenia — a dangerous complication of chemotherapy where the white cell count drops dangerously low and infection sets in — is one of the most serious chemotherapy side effects. G-CSF agents (Filgrastim, Pegfilgrastim/Neulasta, Lenograstim) stimulate the bone marrow to produce neutrophils, significantly reducing the depth and duration of neutropenia. At our centre, prophylactic G-CSF is prescribed for high-risk chemotherapy regimens (where febrile neutropenia risk exceeds 20%) and is used therapeutically in patients who develop neutropenia. This allows patients to maintain their chemotherapy schedule without dose delays or reductions, maximising the chance of successful treatment outcomes. Administration is straightforward via subcutaneous injection and can be self-administered after proper instruction.

📋 Treatment Overview

📅 Schedule a Consultation

Talk to Dr. Joshi about whether this treatment is right for you. OPD: Mon–Thu, 10 AM – 1 PM.